Publications by authors named "D Naber"

Claim this Profile
R
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.
Oliver D Howes, Bernard R Bukala, Eric Y H Chen, Christoph U Correll, Alkomiet Hasan, Dieter Naber

Am J Psychiatry· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of clozapine versus second-generation antipsychotics in people with treatment-resistant schizophrenia: a systematic review and individual patient data meta-analysis.
Johannes Schneider-Thoma, Tasnim Hamza, Konstantina Chalkou, Spyridon Siafis, Shimeng Dong, Dieter Naber

Lancet Psychiatry· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM.
Robert Litman, Dieter Naber, Lourdes Anta, Javier Martínez, Yuriy Filts

Neuropsychiatr Dis Treat· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With Schizophrenia.
Stephan Heres, Joachim Cordes, Sandra Feyerabend, Christian Schmidt-Kraepelin, Richard Musil, Dieter Naber

Schizophr Bull· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study" [Schizophr. Res. 239 (2022) 83-91].
Yuriy Filts, Robert E Litman, Javier Martínez, Lourdes Anta, Dieter Naber

Schizophr Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis